Anti-PVRIG/CD112R antibody [EPR26274-202] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal PVRIG/CD112R antibody. Carrier free. Suitable for WB and reacts with Mouse, Human samples.
View Alternative Names
C7orf15, PVRIG, Transmembrane protein PVRIG, CD112 receptor, Poliovirus receptor-related immunoglobulin domain-containing protein, CD112R
- WB
Supplier Data
Western blot - Anti-PVRIG/CD112R antibody [EPR26274-202] - BSA and Azide free (AB307596)
This data was developed using ab307595, the same antibody clone in a different buffer formulation. Blocking and diluting buffer and concentration : 5% NFDM/TBST. Exposure times : Lane 1 : 10 seconds Lane 2 and 3 : 1 second
All lanes:
Western blot - Anti-PVRIG/CD112R antibody [EPR26274-202] (<a href='/en-us/products/primary-antibodies/pvrig-cd112r-antibody-epr26274-202-ab307595'>ab307595</a>) at 1/1000 dilution
Lane 1:
Human spleen tissue lysate at 20 µg
Lane 2:
Mouse spleen tissue lysate at 20 µg
Lane 3:
Mouse lymph node tissue lysate at 20 µg
Secondary
All lanes:
Western blot at 1/2000 dilution
Observed band size: 30 kDa
false
- WB
Supplier Data
Western blot - Anti-PVRIG/CD112R antibody [EPR26274-202] - BSA and Azide free (AB307596)
This data was developed using ab307595, the same antibody clone in a different buffer formulation. Blocking and diluting buffer and concentration : 5% NFDM/TBST. Negative control : HeLa Exposure time : 180 seconds.
All lanes:
Western blot - Anti-PVRIG/CD112R antibody [EPR26274-202] (<a href='/en-us/products/primary-antibodies/pvrig-cd112r-antibody-epr26274-202-ab307595'>ab307595</a>) at 1/1000 dilution
Lane 1:
Daudi (human Burkitts lymphoma lymphoblast) whole cell lysate at 20 µg
Lane 2:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 30 kDa
false
Exposure time: 180s
Related conjugates and formulations (1)
-
Anti-PVRIG/CD112R antibody [EPR26274-202]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PVRIG impacts immune cell behavior and is part of the inhibitory receptor family. Its primary role is to fine-tune the immune response by decreasing overactivation helping to maintain immune homeostasis. PVRIG interacts with other immune inhibitory receptors like TIGIT and PD-1 forming a complex network that suppresses overactive T cell responses. This process is important for preventing autoimmune reactions while allowing normal immune surveillance.
Pathways
PVRIG participates in immune checkpoint pathways that influence T cell regulation. It plays a role in the immune checkpoint receptor pathway which is pivotal for controlling immune tolerance and immune-mediated inflammation. Within these pathways PVRIG works closely with other receptors like PD-1 forming a blockade that maintains the balance of immune activation and inhibition and participates in the immune synapse during antigen presentation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com